Clinical diagnosis and treatment of immune checkpoint inhibitor‐associated pneumonitis
出版年份 2019 全文链接
标题
Clinical diagnosis and treatment of immune checkpoint inhibitor‐associated pneumonitis
作者
关键词
-
出版物
Thoracic Cancer
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2019-11-25
DOI
10.1111/1759-7714.13240
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The Relationship between Prior Radiotherapy and Checkpoint-Inhibitor Pneumonitis in Patients with Advanced Non-Small Cell Lung Cancer
- (2019) Khinh Ranh Voong et al. Clinical Lung Cancer
- Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials
- (2019) Yucai Wang et al. JAMA Oncology
- Evaluation of Readministration of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer
- (2019) Audrey Simonaggio et al. JAMA Oncology
- Immune checkpoint immunotherapy for non-small cell lung cancer: benefits and pulmonary toxicities
- (2018) Karthik Suresh et al. CHEST
- Incidence, Risk Factors, and Effect on Survival of Immune-related Adverse Events in Patients With Non–Small-cell Lung Cancer
- (2018) Dwight H. Owen et al. Clinical Lung Cancer
- Pneumonitis in Non-Small Cell Lung Cancer patients receiving Immune Checkpoint Immunotherapy: incidence and risk factors
- (2018) Karthik Suresh et al. Journal of Thoracic Oncology
- Characteristics, incidence, and risk factors of immune checkpoint inhibitor-related pneumonitis in patients with non-small cell lung cancer
- (2018) Jun Yeun Cho et al. LUNG CANCER
- Pre-existing pulmonary fibrosis is a risk factor for anti-PD-1-related pneumonitis in patients with non-small cell lung cancer: A retrospective analysis
- (2018) Teppei Yamaguchi et al. LUNG CANCER
- The Relative Risk and Incidence of Immune Checkpoint Inhibitors Related Pneumonitis in Patients With Advanced Cancer: A Meta-Analysis
- (2018) Ke Ma et al. Frontiers in Pharmacology
- Comprehensive Meta-analysis of Key Immune-Related Adverse Events from CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients
- (2017) Guillermo De Velasco et al. Cancer Immunology Research
- Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade
- (2017) Chipman RG Stroud et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Efficacy and toxicity of rechallenge with combination immune checkpoint blockade in metastatic melanoma: a case series
- (2016) Lavinia Spain et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- PD-1 Inhibitor-Related Pneumonitis in Advanced Cancer Patients: Radiographic Patterns and Clinical Course
- (2016) M. Nishino et al. CLINICAL CANCER RESEARCH
- Anti-PD1 Antibody Treatment and the Development of Acute Pulmonary Tuberculosis
- (2016) Kohei Fujita et al. Journal of Thoracic Oncology
- Incidence of Programmed Cell Death 1 Inhibitor–Related Pneumonitis in Patients With Advanced Cancer
- (2016) Mizuki Nishino et al. JAMA Oncology
- Opportunistic infections in patients treated with immunotherapy for cancer
- (2014) Chrisann Kyi et al. Journal for ImmunoTherapy of Cancer
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More